Insys Plans $29M CBD And Naloxone Sale In Ch. 11 - Law360
08/09/19
Insys Plans $29M CBD And Naloxone Sale In Ch. 11 Law360
Embattled and bankrupt drugmaker Insys Therapeutics Inc. has entered into agreements to sell the company's naloxone spray and cannabis-based products to ...
[more]